Search - tctmd.com

Displaying 161 - 180 of 203

Sort: Relevancy | Date

Presentation ACC 2025

STRIDE - Semaglutide and walking capacity in people with symptomatic peripheral artery disease and type 2 diabetes

Presenter: Marc P. Bonaca

March 29, 2025

News Daily News ACC 2025

STRIDE: GLP-1 Boosts Walking Capacity in Diabetic PAD Patients

L.A. McKeown

March 29, 2025

Presentation ACC 2025

Extended Anticoagulant Treatment With A Reduced Versus Full Dose Apixaban In Patients With Cancer-associated Venous Thromboembolism: The API-CAT Study

Presenter: Isabelle Mahé

March 29, 2025

News Conference News ACC 2025

Low-Dose Apixaban Prevents Recurrent VTE in Cancer Beyond 6 Months: API-CAT

Caitlin E. Cox

March 29, 2025

News Opinion Editor's Corner ACC 2025

What’s Going to Be Hot at ACC 2025?

Michael O'Riordan

March 26, 2025

News Daily News

SONOBIRDIE: Ultrasound Appears to Make Carotid Endarterectomy Safer

Todd Neale

March 25, 2025

News Daily News

Take Heed of Sex Differences in Peripheral Vascular Disease: AHA

Michael O'Riordan

March 13, 2025

News Daily News

Coverage and Use of Impella and Watchman: A Tale of Four Countries

Michael O'Riordan

March 04, 2025

News Daily News

FDA Approves Tenecteplase for Acute Ischemic Stroke

Michael O'Riordan

March 03, 2025

News Daily News

Philips Recalls Tack Endovascular Systems and Stops Distribution

L.A. McKeown

March 03, 2025

News Daily News

Survey Calls Out Implicit Bias in Peripheral Vascular Care

L.A. McKeown

February 28, 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for February 2025

Shelley Wood

February 28, 2025

News Daily News

AHA Scientific Statement Takes Aim at PAD Pain

L.A. McKeown

February 13, 2025

Presentation THT 2025

Win Ratio Analysis of Endovascular Ablation of the Right Greater Splanchnic Nerve in Heart Failure With Preserved Ejection Fraction: REBALANCE-HF Randomized Trial

Presenter: Marat Fudim

February 12, 2025

Presentation THT 2025

Worsening Renal Function Is Common And Associated With Increased Mortality In Cardiogenic Shock: An Analysis From The Multi-Center Cardiogenic Shock Working Group (CSWG) Registry

Presenter: Rachna Kataria

February 12, 2025

Presentation THT 2025

Acute PE Risk Stratification: Where Do Hemodynamics Fit In?

Presenter: Eric Secemsky

February 12, 2025

Presentation THT 2025

Case Presentation: Submassive PE With Normotensive Shock

Presenter: Maya Serhal

February 12, 2025

Presentation THT 2025

Role of MCS in PE Management

Presenter: Karthikeyan Ranganathan

February 12, 2025

Presentation THT 2025

When to Use Devices the Recude Renal Vein Pressure

Presenter: Liviu Klein

February 12, 2025

News Conference News ISC 2025

GFAP Biomarker Assay Can Discern ICH vs Ischemic Stroke

Caitlin E. Cox

February 11, 2025

Advertisement

STRIDE - Semaglutide and walking capacity in people with symptomatic peripheral artery disease and type 2 diabetes

STRIDE: GLP-1 Boosts Walking Capacity in Diabetic PAD Patients

Extended Anticoagulant Treatment With A Reduced Versus Full Dose Apixaban In Patients With Cancer-associated Venous Thromboembolism: The API-CAT Study

Low-Dose Apixaban Prevents Recurrent VTE in Cancer Beyond 6 Months: API-CAT

What’s Going to Be Hot at ACC 2025?

SONOBIRDIE: Ultrasound Appears to Make Carotid Endarterectomy Safer

Take Heed of Sex Differences in Peripheral Vascular Disease: AHA

Coverage and Use of Impella and Watchman: A Tale of Four Countries

FDA Approves Tenecteplase for Acute Ischemic Stroke

Philips Recalls Tack Endovascular Systems and Stops Distribution

Survey Calls Out Implicit Bias in Peripheral Vascular Care

TCTMD’s Top 10 Most Popular Stories for February 2025

AHA Scientific Statement Takes Aim at PAD Pain

Win Ratio Analysis of Endovascular Ablation of the Right Greater Splanchnic Nerve in Heart Failure With Preserved Ejection Fraction: REBALANCE-HF Randomized Trial

Worsening Renal Function Is Common And Associated With Increased Mortality In Cardiogenic Shock: An Analysis From The Multi-Center Cardiogenic Shock Working Group (CSWG) Registry

Acute PE Risk Stratification: Where Do Hemodynamics Fit In?

Case Presentation: Submassive PE With Normotensive Shock

Role of MCS in PE Management

When to Use Devices the Recude Renal Vein Pressure

GFAP Biomarker Assay Can Discern ICH vs Ischemic Stroke

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content